Explore The Innovation Antibody and how organizational resistance can kill innovation from within, undermining growth, adaptability, and long-term competitiveness in rapidly changing markets The ...

New-onset interstitial lung disease can be detected up to 10 years after initial negative screening in patients with systemic sclerosis, with a higher mortality risk vs those without lung involvement.

Discover the top 3 manufacturing mistakes CDMOs make and how to prevent them when scaling for next-generation oncology.

Doctors often say labs look “normal.” Dr. Mark Hyman explains why that doesn’t always reflect wellness, and what early ...

The 2025 American Society of Hematology (ASH) meeting in December presented a clear message: scientific innovation and ...

Background Autoimmune neutropenia (AIN) is the main cause of chronic neutropenia in children, but its infectious consequences ...

The Linux Foundation's CAMARA project, an open source community addressing telco industry API interoperability, today announced the release of a new white paper, "In Concert: Bridging AI Systems & ...

The data illustrate that several patients remained on zenocutuzumab well beyond progression, including multiple patients who continued treatment for more than one- or two-years post-progression.

Digital transformation is expected to become an integral part of Swiss companies' strategic plans, with a growing demand for cloud services to support AI applications, according to a new research ...

The answer depends on the question -- and what the patient really wants ...

Cerebral arteriovenous malformations (AVMs) are an uncommon type of central nervous system vascular anomaly that have the potential to rupture and cause intracranial hemorrhage. AVM hemorrhagic risk ...

By Brad Sorensen, CFA NASDAQ:YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial ...